Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.
- NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_assertion description "[We found that inhibitory receptor KIR2DL1 in combination with HLA-C2 ligand confers susceptibility to chronic hepatitis B (CHB), whereas inhibitory receptor KIR2DL3 or KIR2DL3 homozygote in the presence of HLA-C1C1 genotype shows protection against CHB.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.
- NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_assertion evidence source_evidence_literature NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.
- NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_assertion SIO_000772 20643584 NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.
- NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_assertion wasDerivedFrom befree-20140225 NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.
- NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_assertion wasGeneratedBy ECO_0000203 NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP381615.RANz28ax3EHgSB_BWmi0FN8WUZ_HiRBlB_ImWZ_i-26Gg130_provenance.